Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2021

View Archived Issues

Overcoming EGFR-targeted TKI lung cancer resistance

Sulfopin, a new selective Pin1 inhibitor with in vivo anticancer activity in Myc-driven tumors

Engineered microbial therapy for local metabolic modulation of the tumor microenvironment

AMPK is a therapeutic target in PDAC

BDNF and NSE as biomarkers in alcohol use disorder and mood disorder comorbidity

New EGFR inhibitors identified at PharmaBlock Sciences

Heptares Therapeutics describes new GLP-1 and GLP-2 receptor agonists

LG Chem discovers GLP-1 receptor agonists

Beijing Jacobio Pharmaceuticals patents KRAS mutant protein inhibitors

New adenosine receptor antagonists synthesized at Exelixis

Suicide attempters with schizophrenia show increased serum S-100B protein levels

CD38 as therapeutic target for protection against doxorubicin-induced cardiotoxicity

Ikena Oncology targets TEAD transcription in cancer with IK-930

BNIP3L is a molecular target in mitophagy defects and mitochondrial dysfunction

SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Immusoft and Takeda to jointly develop cell therapies for neurometabolic disorders

Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...